What This Case Supports, and What It Does Not

The guided patient's diagnosis rests on two same-day results, fasting glucose 131 mg/dL and A1c 7.1%, both above their respective ADA thresholds, satisfying the two-abnormal-result confirmation rule without a repeat draw. The triage point-of-care glucose of 142 mg/dL and, in the broader case set, an A1c of 5.9% flagged for possible variant interference, were correctly excluded from the decision because each was outside its validated diagnostic role, not because either number was implausible.

What this content does not resolve: the exact numeric thresholds shown here come from the 2026 ADA Standards of Care and must be reverified against whatever edition is current when this content is read; the document is reissued annually and thresholds or categories can change. The precise magnitude of iron-deficiency effects on A1c is recognized but not quantified well enough here to state a number. Gestational diabetes criteria, the one-step and two-step strategies, and their institution-specific screening cutoffs are a separate framework from the adult criteria covered here and are not interchangeable with them.

What depends on local policy: the analyzer, reagent, and software version behind any A1c or glucose result; specimen stability time and temperature limits beyond the general handling principles covered here; point-of-care meter QC frequency and alternative performance assessment schedule; the choice of one-step versus two-step gestational testing and which abnormal-value rule applies; and which second-line assay, glycated albumin or fructosamine, a laboratory uses when A1c is judged unreliable. None of those are facts that can be supplied on a specific laboratory's behalf.

A defensible diagnostic call names the specific tests used, the specific thresholds applied and their edition, and explicitly states which available results were excluded and why.